WCN 2023

October 15-19, 2023
Montreal, CAN

World Congress of Neurology
Explore more Neuroscience congress materials
Material Type

Results(4)

Neuroscience
Nonseizure outcomes with cannabidiol in pediatric versus adult patients with Lennox-Gastaut syndrome and Dravet syndrome: subgroup analysis of BECOME, a caregiver survey
Author(s): Timothy B. Saurer Ph.D., Jazz Pharmaceuticals
Neuroscience
View Poster
Seizure outcomes with cannabidiol in pediatric versus adult patients with Lennox-Gastaut syndrome and Dravet syndrome: subgroup analysis of BECOME, a caregiver survey
Author(s): Timothy B. Saurer Ph.D., Jazz Pharmaceuticals
Neuroscience
View Poster
Long-term safety and efficacy of add-on cannabidiol (CBD) for seizures associated with tuberous sclerosis complex (TSC): 3-year results from GWPCARE6 open-label extension (OLE)
Author(s): James Wheless MD, Le Bonheur Children’s Hospital and the University of Tennessee Health Science Center
Neuroscience
View Poster
Behavioral outcomes of treatment with cannabidiol oral solution in individuals with seizures associated with tuberous sclerosis complex: design of an ongoing phase 4 trial (EpiCom)
Author(s): Agnies Van Eeghen MD, Emma Children’s Hospital, Amsterdam University Medical Center, Amsterdam; The Netherlands‘s and Advisium, ‘s Heeren Loo, Amersfoort, The Netherlands
Neuroscience
View Poster